- Home
- MUR vs PRCT Comparison
MUR vs PRCT Comparison
Compare MUR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUR
- PRCT
- Stock Information
- Founded
- MUR 1950
- PRCT 2009
- Country
- MUR United States
- PRCT United States
- Employees
- MUR N/A
- PRCT N/A
- Industry
- MUR Oil & Gas Production
- PRCT Medical Specialities
- Sector
- MUR Energy
- PRCT Health Care
- Exchange
- MUR Nasdaq
- PRCT Nasdaq
- Market Cap
- MUR 4.5B
- PRCT 4.7B
- IPO Year
- MUR N/A
- PRCT 2021
- Fundamental
- Price
- MUR $31.49
- PRCT $69.75
- Analyst Decision
- MUR Hold
- PRCT Strong Buy
- Analyst Count
- MUR 13
- PRCT 7
- Target Price
- MUR $39.58
- PRCT $97.86
- AVG Volume (30 Days)
- MUR 1.9M
- PRCT 656.5K
- Earning Date
- MUR 01-30-2025
- PRCT 02-25-2025
- Dividend Yield
- MUR 3.82%
- PRCT N/A
- EPS Growth
- MUR N/A
- PRCT N/A
- EPS
- MUR 3.09
- PRCT N/A
- Revenue
- MUR $3,191,294,000.00
- PRCT $199,843,000.00
- Revenue This Year
- MUR N/A
- PRCT $67.07
- Revenue Next Year
- MUR N/A
- PRCT $40.64
- P/E Ratio
- MUR $10.20
- PRCT N/A
- Revenue Growth
- MUR N/A
- PRCT 71.71
- 52 Week Low
- MUR $27.75
- PRCT $44.52
- 52 Week High
- MUR $49.14
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- MUR 49.47
- PRCT 25.89
- Support Level
- MUR $30.57
- PRCT $79.56
- Resistance Level
- MUR $34.14
- PRCT $89.49
- Average True Range (ATR)
- MUR 0.92
- PRCT 4.14
- MACD
- MUR 0.18
- PRCT -1.11
- Stochastic Oscillator
- MUR 46.84
- PRCT 6.09
About MUR Murphy Oil Corporation
Murphy Oil Corp is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.